# Samy Hadjadj

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/samy-hadjadj/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,254 |
| Field | Diabetes Treatment and Management |
| h-index | 47 |
| i10-index | 163 |
| Last Known Institution | Centre National de la Recherche Scientifique |
| OpenAlex ID | https://openalex.org/A5039339457 |
| ORCID iD | 0000-0001-7110-6994 |
| Works | 412 |

## Researcher papers

Showing 12 of 15.

- [A genome-wide association study identifies novel risk loci for type 2 diabetes](https://scholariq.org/papers/a-genome-wide-association-study-identifies-novel-risk-loci-for-type-2-diabetes/)
- [Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis](https://scholariq.org/papers/twelve-type-2-diabetes-susceptibility-loci-identified-through-large-scale/)
- [Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study](https://scholariq.org/papers/phenotypic-characteristics-and-prognosis-of-inpatients-with-covid-19-and/)
- [A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk](https://scholariq.org/papers/a-variant-near-mtnr1b-is-associated-with-increased-fasting-plasma-glucose-levels/)
- [Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia](https://scholariq.org/papers/genetic-variant-near-irs1-is-associated-with-type-2-diabetes-insulin-resistance/)
- [Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes](https://scholariq.org/papers/rare-mtnr1b-variants-impairing-melatonin-receptor-1b-function-contribute-to-type/)
- [Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled/)
- [Effect of a diabetic environment in utero on predisposition to type 2 diabetes](https://scholariq.org/papers/effect-of-a-diabetic-environment-in-utero-on-predisposition-to-type-2-diabetes/)
- [New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes](https://scholariq.org/papers/new-susceptibility-loci-associated-with-kidney-disease-in-type-1-diabetes/)
- [Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled-3/)
- [A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes](https://scholariq.org/papers/a-genome-wide-association-study-of-diabetic-kidney-disease-in-subjects-with-type/)
- [Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial](https://scholariq.org/papers/effects-of-semaglutide-with-and-without-concomitant-sglt2-inhibitor-use-in/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Centre National de la Recherche Scientifique](https://scholariq.org/institutions/centre-national-de-la-recherche-scientifique/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.